People: Affymetrix Inc (AFFX.O)

AFFX.O on Nasdaq

8.74USD
21 Aug 2014
Price Change (% chg)

$0.16 (+1.86%)
Prev Close
$8.58
Open
$8.59
Day's High
$8.74
Day's Low
$8.39
Volume
496,259
Avg. Vol
742,361
52-wk High
$9.80
52-wk Low
$5.10

Search Stocks

Last, Andrew 

Brief Biography

Dr. Andrew J. Last, Ph.D., is Chief Operating Officer, Executive Vice President of Affymetrix Inc. He joined the company in December 2009 and currently serves as Executive Vice President, Genetic Analysis Business Unit.Prior to joining Affymetrix, Dr. Last served on the leadership team of BD Biosciences Cell Analysis Unit, a segment of Becton Dickinson and Company, from 2004 to 2009, where he was Vice President, Global Marketing & Strategic Planning and General Manager of the San Diego-based Pharmingen business. Before joining Becton Dickinson, Dr. Last was a member of Applera Corporation’s Applied Biosystems unit leadership team from 2002 to 2004 as Vice President & General Manager of the Gene Expression business.

Basic Compensation

Total Annual Compensation, USD Long-Term Incentive Plans, USD All Other, USD Fiscal Year Total, USD
376,546 -- 249,417 933,163

Options Compensation

  Quantity Market Value
Exercisable -- --
Unexercisable -- --
Exercised -- --
Name Fiscal Year Total

Stephen Fodor

188,970

Frank Witney

1,759,440

Gavin Wood

954,758

Andrew Last

933,163

David Weber

872,003

Robert Wayman

--
As Of 30 Dec 2013
Search Stocks